Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Presse Med ; 29(4): 186-7, 2000 Feb 05.
Article in French | MEDLINE | ID: mdl-10705894

ABSTRACT

BACKGROUND: Use of powerful multiple-drug antiretroviral regimens can significantly raise CD4+ counts restoring immune function, but in certain cases, leading to inflammatory reactions. CASE REPORT: An HIV-infected patient developed a mycobacteriosis of the digestive tract when his CD4 count fell below 5/mm3. He was given antimycobacterial treatment in combination with an effective triple antiretroviral regimen. At two years, the clinical situation was controlled with persistent optimal response (CD4 = 338/mm3 HIV-RNA < 500 copies/ml); the antimycobacterial regimen was discontinued. One year later the patient still had a CD4+ count above 500/mm3 but developed a voluminous mesenteric mass invaded by a CD68+ histiocyte proliferation. No causal agent could be identified. The clinical course was favorable after reintroducing antimycobacterial treatment combined with short-term corticosteroid therapy. DISCUSSION: Reconstitution of the immune system after long-term use of the new antiretroviral therapies raises the question of whether anti-infectious prophylaxis should be maintained. However, possible reactions to earlier pathogens after restoration of specific immunity would warrant secondary prophylaxis even in patients responding to powerful antiretroviral combinations.


Subject(s)
AIDS-Related Opportunistic Infections/drug therapy , Anti-HIV Agents/therapeutic use , Granuloma/etiology , HIV Infections/drug therapy , HIV Infections/immunology , Lymphadenitis/etiology , Mesentery , Mycobacterium avium , Peritoneal Diseases/etiology , Tuberculosis/drug therapy , AIDS-Related Opportunistic Infections/immunology , Adrenal Cortex Hormones/therapeutic use , Adult , Anti-Bacterial Agents/therapeutic use , Antibiotics, Antitubercular/therapeutic use , Antitubercular Agents/therapeutic use , Biopsy , CD4 Lymphocyte Count , Clarithromycin/therapeutic use , Drug Therapy, Combination/therapeutic use , Ethambutol/therapeutic use , Follow-Up Studies , Granuloma/diagnostic imaging , Granuloma/pathology , Humans , Lymphadenitis/diagnostic imaging , Lymphadenitis/pathology , Male , Mesentery/pathology , Peritoneal Diseases/diagnostic imaging , Peritoneal Diseases/pathology , Rifabutin/therapeutic use , Time Factors , Tomography, X-Ray Computed , Tuberculosis/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...